Published in Health Business Week, March 27th, 2009
"We are quite excited about this trial, since there are no known therapies that to date have effectively targeted K-RAS in cancer patients,"...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.